Brooks Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Brooks Laboratories Ltd. on BSE

Load latest

Brooks Laboratories Ltd.

26 Mar 2025

138.32

4.99%

SAST

Brooks Laboratories Ltd - 533543 - Closure of Trading Window

BSE India

Please find enclosed intimation for closure of Trading window for the quarter and financial year ended 31st March 2025.The details of Board Meeting and opening of Trading Window shall be intimated in due course of time.

pdf

Brooks Laboratories Ltd.

28 Feb 2025

138.32

4.99%

Company Update

BROOKS LABORATORIES LTD. - 533543 - Integrated Filing (Financial) For The Quarter And Nine Months Ended …

BSE India

Revision of Integrated Filing (Financial) for the quarter and nine months ended 31st December 2024.

pdf

Brooks Laboratories Ltd.

28 Feb 2025

138.32

4.99%

Company Update

BROOKS LABORATORIES LTD. - 533543 - Integrated Filing (Financial) For The Quarter And Nine Months Ended …

BSE India

Revision of Integrated Filing (Financial) for the quarter and nine months ended 31st December 2024.

pdf

Brooks Laboratories Ltd.

25 Feb 2025

138.32

4.99%

Company Update

BROOKS LABORATORIES LTD. - 533543 - Outcome Of Board Meeting (Revised).

BSE India

Revision of the outcome of the Board Meeting held on 13th February 2025.

pdf

Brooks Laboratories Ltd.

14 Feb 2025

138.32

4.99%

Company Update

BROOKS LABORATORIES LTD. - 533543 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication dated 14th February 2025 for Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended 31st December 2024.

pdf

Brooks Laboratories Ltd.

13 Feb 2025

138.32

4.99%

Corp. Note

BROOKS LABORATORIES LTD. - 533543 - Integrated Filing (Financial)

BSE India

Integrated Filing (Financial) for the quarter and nine months ended 31st December 2024.

pdf

Brooks Laboratories Ltd.

13 Feb 2025

138.32

4.99%

Result

BROOKS LABORATORIES LTD. - 533543 - Unaudited Financial Results, Both Standalone And Consolidated, For The Quarter …

BSE India

Unaudited Financial results, both standalone and consolidated for the quarter and nine months ended 31st December 2024.

pdf

Brooks Laboratories Ltd.

13 Feb 2025

138.32

4.99%

Board Meeting

BROOKS LABORATORIES LTD. - 533543 - Board Meeting Outcome for Board Meeting Outcome Under Regulation 30 …

BSE India

Outcome of Board Meeting under Regulation 30 & Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015

pdf

Brooks Laboratories Ltd.

10 Feb 2025

138.32

4.99%

Board Meeting

BROOKS LABORATORIES LTD. - 533543 - Board Meeting Intimation for Intimation Under Regulation 29 Of The …

BSE India

BROOKS LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31, 2024 along with Limited Review Report of Statutory Auditors of the Company thereon pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015.

pdf